Anna is a biotechnologist by background who has worked with Mabion for 15 years, including previously in the R&D and QC departments. She supports the navigation of regulatory requirements at different phases of drug development for Mabion clients. She works to ensure that documentation and processes carried out by the company comply with regulatory requirements and leads operational activities for preparation of Scientific Advice procedures, clinical trial documentation, and registration dossiers. Anna left Mabion in 2026.
